JPRN-jRCT2031200212进行中（未招募）未知
Special drug-use survey of Tarlige tablet (evaluation of safety in long-term use)
Matsuoka Yomei0 个研究点目标入组 900 人开始时间: 2020年11月30日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 900
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •(1) Patients with peripheral neuropathic pain not treated with Tarlige tablet before
- •(2) Ambulatory outpatients who were able to visit the clinic unassisted
- •(3) Patients who will continue to administration of Tarlige tablet at the return visit after started of administration (including the start date, 28 days or less)
- •(4) Patients who started administration of Tarlige tablet during the contract period (contract period based on the contract with each medical site)
- •(5) Patients who started administration of Tarlige tablet during the registration period
- •(6) Patients from whom written informed consent was obtained
排除标准
- 未提供
研究者
相似试验
已完成
Unknown
Special drug-use survey of Tarlige (evaluation of the efficacy in patients with peripheral neuropathic pain)JPRN-jRCT1080224913DAIICHI SANKYO CO., LTD1,890
招募中
不适用
Special drug-use survey of Tarlige (central neuropathic pain)Central neuropathic painJPRN-jRCT2031220132Matsuoka for Yomei400
已完成
不适用
Special Drug Use Results Survey of Targretin capsules 75-mg in patients with Cutaneous T-cell LymphomasCutaneous T-Cell LymphomasJPRN-UMIN000022568Minophagen Pharmaceutical Co., Ltd.200
招募中
不适用
Special Drug Use-results Survey of Targretin Capsules combined with photo(chemo)therapyCutaneous T-cell lymphomaJPRN-jRCT2031210625pharmacovigilance departmant70
未知
Unknown
Blopress Tablets specified drug-use survey Hypertension: Survey on patients with metabolic syndromeHypertensionJPRN-jRCT1080222516TAKEDA PHARMACEUTICAL COMPANY LTD.15,000